TY - JOUR
T1 - Distinct Influence of Omega-3 Fatty Acids on the Plasma Metabolome of Healthy Older Adults
AU - Xyda, Souzana Eirini
AU - Vuckovic, Ivan
AU - Petterson, Xuan Mai
AU - Dasari, Surendra
AU - Lalia, Antigoni Z.
AU - Parvizi, Mojtaba
AU - Macura, Slobodan I.
AU - Lanza, Ian R.
N1 - Funding Information:
This work was supported by the Clinical and Translational Science Award KL2 TR-000136, and the CTSA Grant Number UL TR000135 from the National Center for Advancing Translational Sciences, a component of the National Institutes of Health (NIH). Additional funding was provided by the Strickland Career Development Award and U24DK100469 from the National Institute of Diabetes and Digestive and Kidney Diseases, which originates from the NIH Director’s Common Fund. The contents of this work are solely the responsibility of the authors and do not necessarily represent the official views of the National Institutes of Health.
Publisher Copyright:
© 2019 The Author(s) 2019. Published by Oxford University Press on behalf of The Gerontological Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
PY - 2020/4/17
Y1 - 2020/4/17
N2 - Omega-3 polyunsaturated fatty acids (n3-PUFA) are well recognized for their potent triglyceride-lowering effects, but the potential influence of these bioactive lipids on other biological processes, particularly in the context of healthy aging, remains unknown. With the goal of gaining new insight into some less well-characterized biological effects of n3-PUFAs in healthy older adults, we performed metabolomics of fasting peripheral blood plasma collected from 12 young adults and 12 older adults before and after an open-label intervention of n3-PUFA (3.9 g/day, 2.7 g eicosapentaenoic [EPA], 1.2 g docosahexaenoic [DHA]). Proton nuclear magnetic resonance (1H-NMR) based lipoprotein subclass analysis revealed the expected reduction in total triglyceride (TG), but also demonstrated that n3-PUFA supplementation reduced very low-density lipoprotein (VLDL) particle number, modestly increased high-density lipoprotein (HDL) cholesterol, and shifted the composition of HDL subclasses. Further metabolite profiling by 1H-NMR and mass spectrometry revealed pronounced changes in phospholipids, cholesterol esters, diglycerides, and triglycerides following n3-PUFA supplementation. Furthermore, significant changes in hydroxyproline, kynurenine, and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF) following n3-PUFA supplementation provide further insight into some less well-recognized biological effects of n3-PUFA supplementation, including possible effects on protein metabolism, the kynurenine pathway, and glucose metabolism.
AB - Omega-3 polyunsaturated fatty acids (n3-PUFA) are well recognized for their potent triglyceride-lowering effects, but the potential influence of these bioactive lipids on other biological processes, particularly in the context of healthy aging, remains unknown. With the goal of gaining new insight into some less well-characterized biological effects of n3-PUFAs in healthy older adults, we performed metabolomics of fasting peripheral blood plasma collected from 12 young adults and 12 older adults before and after an open-label intervention of n3-PUFA (3.9 g/day, 2.7 g eicosapentaenoic [EPA], 1.2 g docosahexaenoic [DHA]). Proton nuclear magnetic resonance (1H-NMR) based lipoprotein subclass analysis revealed the expected reduction in total triglyceride (TG), but also demonstrated that n3-PUFA supplementation reduced very low-density lipoprotein (VLDL) particle number, modestly increased high-density lipoprotein (HDL) cholesterol, and shifted the composition of HDL subclasses. Further metabolite profiling by 1H-NMR and mass spectrometry revealed pronounced changes in phospholipids, cholesterol esters, diglycerides, and triglycerides following n3-PUFA supplementation. Furthermore, significant changes in hydroxyproline, kynurenine, and 3-carboxy-4-methyl-5-propyl-2-furanpropionic acid (CMPF) following n3-PUFA supplementation provide further insight into some less well-recognized biological effects of n3-PUFA supplementation, including possible effects on protein metabolism, the kynurenine pathway, and glucose metabolism.
KW - DHA
KW - EPA
KW - Lipoproteins
KW - Metabolomics
KW - n3-PUFA
UR - http://www.scopus.com/inward/record.url?scp=85080130985&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85080130985&partnerID=8YFLogxK
U2 - 10.1093/gerona/glz141
DO - 10.1093/gerona/glz141
M3 - Article
C2 - 31168623
AN - SCOPUS:85080130985
SN - 1079-5006
VL - 75
SP - 875
EP - 884
JO - Journals of Gerontology - Series A Biological Sciences and Medical Sciences
JF - Journals of Gerontology - Series A Biological Sciences and Medical Sciences
IS - 5
ER -